DNMT3B and breast carcinoma: Subsequent to determination of the ERα activating role in DNMTs genes, we evaluated the role of ERα-induced DNMTs up-regulation in acquired drug resistance of breast cancer cells by testing whether alteration of DNMT1 and DNMT3b expression change drug sensitivity of breast cancer cells.